You are here

Article Text

Article menu
Download PDFPDF
Rare disease
CASE REPORT
Primary bladder amyloidosis as a cause of haematuria
  1. Alexander Luke Nesbitt1,
  2. Munad Khan2,
  3. Nathan Hoag2,
  4. Julie Lokan3
  1. 1Department of Urology, Cairns Hospital, Cairns, Queensland, Australia
  2. 2Department of Urology, Austin Health, Heidelberg, Victoria, Australia
  3. 3Department of Pathology, Austin Health, Heidelberg, Victoria, Australia
  1. Correspondence to Dr Alexander Luke Nesbitt, alexnesbitt1{at}gmail.com

Summary

We report the case of a 46-year-old man who initially presented with macroscopic haematuria. Although initially concerning for a malignancy in the bladder, histology demonstrated a primary bladder amyloidosis that has remained stable for 6 years since the initial diagnosis. Primary bladder amyloidosis is an important clinical entity that can mimic bladder malignancy on clinical history, radiological investigation and cystoscopic evaluation. Although uncommon, it should not be neglected as a possible diagnosis in patients presenting with haematuria.

  • hematuria
  • urology
  • urological surgery

https://doi.org/10.1136/bcr-2018-225414

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors ALN prepared the majority of the manuscript and was the main author of the case. MK provided assistance with compiling the manuscript and literature review. NH supervised the clinical care of the patient and also contributing to editing the manuscript and guiding the literature review. JL assisted in the pathological diagnosis, guiding the literature review and providing the histopathological images.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.